secwatch.observer — SEC 8-K summary
======================================

Issuer:     ENvue Medical, Inc. (FEED)
CIK:        0001326706
Form:       8-K
Filed at:   2026-01-30T23:59:59+00:00
Accession:  0001493152-26-004523
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 3.03, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ENvue Medical removes Series H Preferred Floor Price in exchange for $2.5M investment
--------------------------------------------------------------------------------

- Entered Amendment Agreement with Required Holders to file Certificate of Amendment removing Floor Price from Series H Convertible Preferred Stock.
- In consideration, holders exercised $2,500,000 of Additional Investment Right from July 2025 purchase agreement.
- Certificate of Amendment filed and effective January 30, 2026.
- The amendment modifies conversion rights of Series H Preferred by eliminating the Floor Price.
- Company receives $2.5M new capital from existing preferred holders.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1326706/000149315226004523/0001493152-26-004523-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1326706/000149315226004523/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-004523

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer